[29P-am] Pharmacology 1

[29P-am263] The epidermal growth factor receptor inhibitor epertinib reverses P-glycoprotein-mediated multidrug resistance in cancer cell lines

Yen-Ching Li¹, Bing-Huan Lin¹, Megumi Murakami², Suresh V Ambudkar², ○Chung-Pu Wu^1,3,4,5 (1. Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan, 2. Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA., 3. Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan., 4. Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei 10507, Taiwan., 5. Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.)